Artelo Biosciences Inc.

NASDAQ: ARTL · Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-10.11M -9.93M -10.29M -7.44M
Interest Income
n/a n/a 2K 2K
Pretax Income
-9.83M -9.29M -10.08M -7.44M
Net Income
-9.83M -9.29M -10.08M -7.44M
Selling & General & Admin
4.12M 4.23M 5.96M 4.6M
Research & Development
5.99M 5.7M 4.32M 2.84M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
10.11M 9.93M 10.29M 7.44M
Interest Expense
n/a n/a 5K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
10.11M 9.93M 10.29M 7.44M
Income Tax Expense
n/a n/a -209K -4K
Shares Outstanding (Basic)
3.22M 2.96M 472K 207.5K
Shares Outstanding (Diluted)
3.22M 2.96M 472.17K 207.5K
EPS (Basic)
-3.05 -3.14 -3.49 -5.97
EPS (Diluted)
-3.05 -3.14 -3.49 -5.97
EBITDA
-10.11M -9.93M -10.29M -7.44M
EBIT
-9.83M -9.29M -10.29M -7.44M
Depreciation & Amortization
n/a n/a 2K -2K